Table 1. Characteristics of ACLF patients with SCA.
Parameters | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 |
Age (years) | 49 | 31 | 35 | 47 | 31 |
Gender | Male | Male | Male | Male | Male |
Etiology of ACLF (acute/chronic) | Alcohol/alcohol | Alcohol/alcohol | Hepatitis E/alcohol | Hepatitis E/alcohol | alcohol/alcohol |
Child-Pugh Score | 13 | 14 | 13 | 12 | 12 |
Hemoglobin (g/dL) | 6.6 | 6.4 | 6.7 | 6.6 | 7.3 |
MCV (fL/cell) | 105 | 105 | 96 | 100 | 99 |
MCH (pg/cell) | 34 | 36 | 35 | 37 | 36 |
MCHC (g/dL) | 34 | 35 | 36 | 37 | 36 |
Reticulocyte count (%) | 1.9 | 2.27 | 6.3 | 3.1 | 2.3 |
Total leukocyte count/cmm | 14000 | 8800 | 9100 | 6200 | 30300 |
Platelets count/cmm | 129000 | 50000 | 40000 | 70000 | 208000 |
Serum LDH (U/L) | 330 | 765 | 880 | 610 | 702 |
Serum ferritin (ng/mL) | 601 | 363 | 2130 | 224 | 446 |
Serum vitamin B12 (ng/mL) | 1500 | 1277 | 714 | 960 | 1063 |
Serum total bilirubin (mg/dL) | 29.5 | 19.7 | 35.3 | 34.8 | 31.5 |
Indirect bilirubin (mg/dL) | 14.9 | 11.6 | 19.3 | 18.5 | 17 |
Serum AST (IU/L) | 62 | 60 | 99 | 161 | 133 |
Serum ALT (IU/L) | 36 | 41 | 93 | 92 | 25 |
Serum albumin (mg/dL) | 3.3 | 3.6 | 2.2 | 2.8 | 2.7 |
INR | 2.5 | 2.9 | 3.5 | 3.0 | 3.9 |
Serum Creatinine (mg/dL) | 1.18 | 1.1 | 0.7 | 0.6 | 0.7 |
Serum total cholesterol (mg/dL) | 37 | 34 | 38 | 63 | 42 |
Serum LDL cholesterol (mg/dL) | 10 | 8.6 | 5.7 | 19 | 13 |
Serum HDL cholesterol (mg/dL) | 05 | 10.7 | 7.1 | 12 | 11 |
Serum Triglyceride (mg/dL) | 51 | 30 | 34 | 32 | 35 |
MELD score | 31 | 30 | 34 | 32 | 35 |
In-hospital complications | Hep enceph, AKI | Hep enceph, AKI, diffuse alveolar hemorrhage | Hep enceph, AKI, variceal bleeding | Hep enceph, variceal bleeding | Hep enceph, variceal bleeding AKI |
Hospital outcome | Discharged | Died | Died | Discharged (against medical advice) | Died |